Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
After-hours: Aug 15, 2025, 07:52 PM EDT

Assembly Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 9.42M 7.36M 6.84M 8.53M 5.79M 7.16M n/a n/a n/a n/a n/a n/a n/a n/a 6.25M n/a n/a
Cost of Revenue
n/a n/a 64K n/a 32K 32K 84K 116K 126K 124K 124K 134K 120K 120K 120K 18.47M 120K 107K
Gross Profit
n/a 9.42M 7.33M 6.84M 8.5M 5.75M 7.08M -116K -126K -124K -124K -134K -120K -120K -120K -12.22M -120K -107K
Operating Income
-11.09M -9.94M -11.53M -10.96M -12.2M -10.73M -12.55M -15.05M -17.49M -19.56M -22.98M -23.4M -24.57M -23.16M -62.89M -18.88M -23.67M -27.26M
Interest Income
n/a 1.12M 1.12M 1.34M 1.46M 1.65M 1.62M 628K 592K 609K 583K 256K 112K 71K 101K 72K 71K 58K
Pretax Income
-10.2M -8.82M -10.41M -9.61M -10.75M -9.08M -10.93M -14.42M -16.9M -18.95M -22.39M -23.14M -24.46M -23.09M -62.79M -18.8M -23.59M -27.2M
Net Income
-10.2M -8.82M -10.34M -9.61M -11.15M -9.08M -10.96M -14.42M -16.9M -18.34M -21.63M -22.89M -24.35M -23.02M -60.26M -18.8M -23.59M -27.2M
Selling & General & Admin
4.59M 4.51M 4.61M 4.29M 4.45M 4.6M 8.62M 4.22M 4.96M 5.01M 6.13M 5.27M 6.78M 5.96M 6.5M 6.66M 6.92M 8.7M
Research & Development
16.13M 14.85M 14.28M 13.52M 16.26M 11.88M 11.01M 10.82M 12.52M 14.55M 16.85M 18.13M 17.79M 17.2M 14.75M 18.47M 16.75M 18.55M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
20.72M 19.36M 18.89M 17.8M 20.7M 16.48M 19.63M 15.05M 17.49M 19.56M 22.98M 23.4M 24.57M 23.16M 21.25M 25.13M 23.67M 27.26M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -32K -32K -84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 19.36M 19.02M 17.8M 20.74M 16.51M 19.71M 15.05M 17.49M 19.56M 22.98M 23.4M 24.57M 23.16M 21.25M 25.13M 23.67M 27.26M
Income Tax Expense
n/a n/a -76K n/a 406K -11.28K 33K -116K 3.92K -609K -766K -256K -112K -71K -2.53M n/a n/a n/a
Shares Outstanding (Basic)
7.66M 7.51M 6.58M 6.35M 5.64M 5.48M 5.48M 4.38M 4.36M 4.25M 4.07M 48.45M 48.29M 48.12M 44.95M 45.57M 42.88M 39.68M
Shares Outstanding (Diluted)
7.66M 7.51M 6.58M 6.35M 5.64M 5.48M 5.48M 4.38M 4.36M 4.25M 4.07M 48.45M 48.29M 48.12M 45.57M 45.57M 42.88M 39.68M
EPS (Basic)
-1.33 -1.17 -1.72 -1.51 -1.98 -1.66 -2 -3.29 -3.88 -4.31 -5.32 -0.47 -0.5 -0.48 -1.34 -0.41 -0.55 -0.69
EPS (Diluted)
-1.33 -1.17 -1.72 -1.51 -1.98 -1.66 -2 -3.29 -3.88 -4.31 -5.32 -0.47 -0.5 -0.48 -1.32 -0.41 -0.55 -0.69
EBITDA
-11.09M -9.91M -11.5M -10.92M -12.17M -10.7M -12.47M -14.93M -17.36M -19.43M -22.85M -23.4M -24.34M -23.04M -18.38M -18.76M -23.55M -27.15M
EBIT
-10.2M -9.94M -11.53M -10.96M -12.2M -10.73M -12.55M -15.05M -17.49M -19.56M -22.39M -23.4M -24.46M -23.16M -21.25M -18.88M -23.67M -27.26M
Depreciation & Amortization
n/a 33K 32K 33K 32K 32K 84K 116K 126K 124K 124K 134K 120K 120K 120K 119K 120K 107K